Prevent Cancer- Greenville

NCT ID: NCT04947098

Last Updated: 2025-02-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-08

Study Completion Date

2029-11-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prevent Cancer-Greenville was created to provide individuals with the opportunity to have their risk of developing cancer studied. Some individuals may be at a higher risk due to their personal lifestyle, family history and/or exposures. If subjects are found to be at high risk for developing a disease, they will be sent to a healthcare provider for further care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants' personal history, lifestyle behaviors and blood, urine, and cheek swab specimens will be used to detect changes or trends that might put them at risk for developing cancer. Some individuals may be at an above average risk of cancer due to lifestyle, family background, personal genetic makeup, or environmental exposures. This will be determined by a process called risk stratification. Risk stratification involves looking at all health-related aspects of a person, determining their individualized risk through screening, and educating them on measures to reduce potential for disease. Participants will complete a yearly health assessment which includes measurements for nutrition, activity, individual risk factors and body composition, including weight height and a special scale which measures fluid and fat.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer High-Risk Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years or older
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Prisma Health-Upstate

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joe Stephenson, MD

Role: PRINCIPAL_INVESTIGATOR

Prisma Health-Upstate

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Prisma Health-Upstate

Greenville, South Carolina, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Patricia Wilson, MSN Ed. OCN ONNCG

Role: CONTACT

864-455-4897

Rachel Zeigler, MS

Role: CONTACT

864-455-6251

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Patricia Wilson, MSN Ed. OCN ONNCG

Role: primary

864-455-4897

Rachel Zeigler, MS

Role: backup

864-455-6251

Related Links

Access external resources that provide additional context or updates about the study.

http://www.aicr.org

Education resources

http://www.cancer.org

Screening guidelines

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Pro00077309

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Family History Study on Cancer Risk
NCT04145388 ACTIVE_NOT_RECRUITING NA
Cohort Study of Pancreatic Cancer Risk
NCT04247503 ACTIVE_NOT_RECRUITING
Genetic Susceptibility to Bladder Cancer
NCT00848289 ACTIVE_NOT_RECRUITING
Norris ORIEN Total Cancer Care
NCT02970045 RECRUITING
Web-based Family History Tool
NCT04890327 COMPLETED NA